analyst
HI
NYSE · HIMS
Hims & Hers Health, Inc.
Healthcare · Medical - Equipment & Services
$30.43
Up+$1.08 (+3.68%)
Updated Sep 23, 2026, 5:43 AM
SID Score
3.8/10
Composite research score
Smart Money
63/100
Neutral
- Market cap
- 8.28B
- P/E ratio
- 63.9
- Dividend yield
- 0.00%
- 52-week range
- $13.74 – $65.30
- Volume
- 16.65M
- Avg. volume
- 27.1M
Price performance
HIMS price history
1M range · 20 trading sessions · Daily adjusted prices
HIMS closed at $30.43 after 20 trading sessions, down 4.16% for the selected period.
- Last close
- $30.43
- Period change
- -4.16%
- Period low
- $27.44
- Period high
- $31.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 22, 2026 | $29.95 | $31.81 | $29.2167 | $30.43 | 16.65M |
| Sep 21, 2026 | $28.50 | $29.525 | $28.18 | $29.35 | 8.45M |
| Sep 18, 2026 | $28.86 | $29.01 | $27.703 | $27.99 | 9.4M |
| Sep 17, 2026 | $28.75 | $28.92 | $27.65 | $27.89 | 8.24M |
| Sep 16, 2026 | $27.76 | $28.55 | $27.46 | $28.00 | 7.35M |
| Sep 15, 2026 | $28.30 | $29.16 | $27.80 | $27.85 | 8.16M |
| Sep 14, 2026 | $27.38 | $29.44 | $27.14 | $28.81 | 11.98M |
| Sep 11, 2026 | $27.41 | $27.63 | $26.73 | $27.51 | 7.09M |
| Sep 10, 2026 | $27.30 | $28.00 | $27.1205 | $27.44 | 7.57M |
| Sep 9, 2026 | $28.10 | $28.28 | $27.27 | $27.90 | 8.44M |
| Sep 8, 2026 | $27.73 | $28.33 | $27.61 | $28.17 | 8.57M |
| Sep 4, 2026 | $27.73 | $27.95 | $27.38 | $27.71 | 7.18M |
| Sep 3, 2026 | $28.88 | $29.12 | $27.55 | $27.82 | 12.21M |
| Sep 2, 2026 | $28.33 | $29.375 | $28.15 | $28.68 | 7.9M |
| Sep 1, 2026 | $29.28 | $29.87 | $28.38 | $28.44 | 7.3M |
| Aug 31, 2026 | $28.67 | $29.7898 | $28.63 | $29.58 | 8.31M |
| Aug 28, 2026 | $31.36 | $31.40 | $28.52 | $28.84 | 14.73M |
| Aug 27, 2026 | $30.40 | $31.985 | $29.7244 | $31.66 | 9.62M |
| Aug 26, 2026 | $31.04 | $31.6295 | $29.62 | $29.83 | 11.58M |
| Aug 25, 2026 | $31.29 | $32.51 | $30.73 | $31.75 | 9.64M |
Latest HIMS news
The latest Smart Investors Daily articles mentioning HIMS.
Stock researchResearch & News · Analysis
Loading stock research…